Example: Heart Attack

Clinical Trials on Hereditary Leiomyomatosis and Renal Cell Cancer

Total 8 results

    • NCT04603365
      Not yet recruiting
      Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer
      Conditions: Clear Cell Papillary Renal Neoplasm; Collecting Duct Carcinoma; Hereditary Leiomyomatosis and Renal Cell Carcinoma; Hereditary Papillary Renal Cell Carcinoma; Metastatic Renal Cell Carcinoma; Metastatic Unclassified Renal Cell Carcinoma; Papillary Renal Cell Carcinoma; Stage III Renal Cell Cancer American Joint Committee on Cancer (AJCC) v8; Stage IV Renal Cell Cancer AJCC v8; Tubulocystic Renal Cell Carcinoma; Unresectable Renal Cell Carcinoma
    • NCT01130519
      Active, not recruiting
      A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
      Conditions: HLRCC; Sporadic Papillary Renal Cell Cancer
    • NCT00971620
      Completed
      Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin
      Conditions: Cutaneous Leiomyomas; Hereditary Leiomyomatosis and Renal Cell Cancer
    • NCT03749980
      Recruiting
      MyVHL: Patient Natural History Study
      Conditions: Von Hippel-Lindau Disease; Hereditary Leiomyomatosis and Renal Cell Cancer; Birt-Hogg-Dube Syndrome; SDHB Gene Mutation
    • NCT00050752
      Recruiting
      Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
      Conditions: Renal Tumor Histology; Cutaneous Leiomyoma; Kidney Cancer
    • NCT04623502
      Recruiting
      An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
      Conditions: Kidney Cancer; Renal Cell Carcinoma; Clear Cell Carcinoma; Urothelial Carcinoma; Metastatic Kidney Cancer; Metastatic Urothelial Carcinoma; Papillary Renal Cell Carcinoma; Chromophobe Renal Cell Carcinoma; Fumarate Hydratase Deficiency; Succinate Dehydrogenase-Deficient Renal Cell Carcinoma; HLRCC; Hereditary Leiomyomatosis and Renal Cell Cancer
    • NCT02495103
      Terminated
      Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
      Conditions: Renal Cell Carcinoma; Hereditary Leiomyomatosis; Renal Cell Cancer
    • NCT00001238
      Recruiting
      Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
      Conditions: Kidney Cancer; Urologic Malignant Disorders; Renal Cell Carcinoma; Clear Cell Renal Cancer; Familial Rena Cancer (FRC)
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations